ArticleBMC ophthalmology2026
Limited clinical relevance of systemic inflammatory indices in idiopathic epiretinal membrane: a retrospective case-control study.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdiopathic epiretinal membrane (iERM) is a common age-related vitreoretinal disorder characterized by fibrocellular proliferation on the inner limiting membrane. Although systemic inflammation has been suggested to play a potential role, the diagnostic value of systemic inflammatory indices such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) remains unclear. This study aimed to evaluate whether the relationships of iERM with clinical and hematological parameters, including age, gender, systemic inflammatory indices and common comorbidities, provide clinically significant additional information.
methodsThis retrospective case–control study included 59 patients with iERM and 56 healthy control subjects. The NLR, PLR, SII were compared between groups. Multivariable logistic regression analyses were performed to identify independent associations with iERM, and receiver operating characteristic (ROC) analyses were used to assess the discriminative performance of systemic inflammatory indices. An additional age-matched sensitivity analysis was conducted to address potential age-related confounding.
resultsPatients with iERM were significantly older than controls (p < 0.001). NLR, PLR, SII, neutrophil, lymphocyte, and platelet values showed no significant difference between groups (all p > 0.05). These findings remained consistent in the age-matched sensitivity analysis, in which 36 patients with iERM were matched to 36 controls, demonstrating no significant differences in systemic inflammatory indices or hematologic parameters between matched groups (all p > 0.05). Comorbidities such as diabetes mellitus and hypertension were not independently associated with iERM (p = 0.918). In multivariable logistic regression models, age remained the only independent predictor of iERM (Model-0: AUC = 0.723). The inclusion of NLR, PLR, or SII did not significantly improve model performance (AUC < 0.02, higher AIC/BIC, lower HL-p). ROC analyses demonstrated low discriminatory ability (NLR: 0.567, PLR: 0.522, SII: 0.568).
conclusionConfirming the limited clinical significance of these readily available biomarkers will be important to avoid unnecessary clinical use of such markers in iERM and present findings may help guide future research toward local retinal mechanisms rather than systemic inflammatory biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.